Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 31 May 2024

Expression and clinical significance of interleukin-6 pathway in cholangiocarcinoma

in Cancer Immunity and Immunotherapy

Dongqing Gu
Xin Zhao
Jing Song
Jianmei Xiao
Leida Zhang
Guohong Deng
Dajiang Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374967

3,133 views
1 citation

Review

Published on 31 May 2024

Tumor glucose metabolism and the T cell glycocalyx: implication for T cell function

in Cancer Immunity and Immunotherapy

Fabian Schuurmans
Kyra E. Wagemans
Gosse J. Adema
Lenneke A. M. Cornelissen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1409238

5,395 views
6 citations

Case Report

Published on 31 May 2024

Successful treatment with tislelizumab plus chemotherapy for SMARCA4-deficient undifferentiated tumor: a case report

in Cancer Immunity and Immunotherapy

Wen Dong
Anli Dai
Zhijun Wu
Jiangtao Wang
Tao Wu
Yangfeng Du
Wei Tian
Jiang Zheng
Yan Zhang
Hongming Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1371379

2,748 views
4 citations

Original Research

Published on 31 May 2024

Role of recombinant human granulocyte colony-stimulating factor in development of cancer-associated venous thromboembolism in lung cancer patients who undergo chemotherapy

in Cancer Immunity and Immunotherapy

Yi Cheng
Yunfeng Zhao
Mei Xu
He Du
Jinyuan Sun
Qihuan Yao
Jianmin Qu
Song Liu
Xuejun Guo
Wei Xiong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1386071

1,758 views

Review

Published on 31 May 2024

From mechanism to therapy: the journey of CD24 in cancer

in Cancer Immunity and Immunotherapy

Kai Zhao
Caifeng Wu
Xiangjun Li
Mengchao Niu
Dan Wu
Xiaofeng Cui
Hai Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1401528

5,952 views
11 citations

Mini Review

Published on 31 May 2024

Unveiling the multifaceted antitumor effects of interleukin 33

in Cancer Immunity and Immunotherapy

Leire Arrizabalaga
Aline Risson
Miriam Ezcurra-Hualde
Fernando Aranda
Pedro Berraondo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425282

3,474 views
6 citations

Editorial

Published on 30 May 2024

Editorial: Mathematical modeling and computational predictions in oncoimmunology

in Cancer Immunity and Immunotherapy

Vladimir A. Kuznetsov
Heiko Enderling
Mark Chaplain

Frontiers in Immunology

doi 10.3389/fimmu.2024.1432372

1,753 views
3 citations

Original Research

Published on 30 May 2024

Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell function

in Cancer Immunity and Immunotherapy

Abdullah Degirmencay
Sharyn Thomas
Angelika Holler
Samuel Burgess
Emma C. Morris
Hans J. Stauss

Frontiers in Immunology

doi 10.3389/fimmu.2024.1386132

5,051 views
3 citations

Mini Review

Published on 30 May 2024

Manipulating regulatory T cells: is it the key to unlocking effective immunotherapy for pancreatic ductal adenocarcinoma?

in Cancer Immunity and Immunotherapy

Henry Smith
Edward Arbe-Barnes
Enas Abu Shah
Shivan Sivakumar

Frontiers in Immunology

doi 10.3389/fimmu.2024.1406250

3,818 views
5 citations

Review

Published on 30 May 2024

Eating away cancer: the potential of diet and the microbiome for shaping immunotherapy outcome

in Cancer Immunity and Immunotherapy

Ngoc-Trang Adrienne Nguyen
Yan Jiang
Jennifer L. McQuade

Frontiers in Immunology

doi 10.3389/fimmu.2024.1409414

5,937 views
8 citations

Original Research

Published on 30 May 2024

The causal effect of adipose tissue on Hodgkin’s lymphoma: two-sample Mendelian randomization study and validation

in Cancer Immunity and Immunotherapy

Lihua Wu
Fei Liao
Xiangli Guo
Nainong Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1400756

3,306 views
3 citations

Editorial

Published on 29 May 2024

Editorial: Spatiotemporal heterogeneity in CNS tumors

in Cancer Immunity and Immunotherapy

Syed M. Faisal
Vidhya M. Ravi
Jason M. Miska

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430227

2,239 views

Editorial

Published on 29 May 2024

Editorial: Novel immune markers and predictive models for immunotherapy and prognosis in breast and gynecological cancers

in Cancer Immunity and Immunotherapy

Fuhao Wang
Qingyu Huang
Shicheng Guo
Alberto Traverso
Feifei Teng
Chao Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1431245

1,753 views
1 citation

Review

Published on 29 May 2024

Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy

in Cancer Immunity and Immunotherapy

Alla Bulashevska
Zsófia Nacsa
Franziska Lang
Markus Braun
Martin Machyna
Mustafa Diken
Liam Childs
Renate König

Frontiers in Immunology

doi 10.3389/fimmu.2024.1394003

12,177 views
13 citations

Review

Published on 29 May 2024

The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Gregory Kenneth Muliawan
Terence Kin-Wah Lee

Frontiers in Immunology

doi 10.3389/fimmu.2024.1400112

4,106 views
5 citations

Review

Published on 29 May 2024

Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy

in Cancer Immunity and Immunotherapy

Naimah Turner
Sarah Hamidi
Rim Ouni
Rene Rico
Ying C. Henderson
Maria Puche
Sayan Alekseev
Jocelynn G. Colunga-Minutti
Mark E. Zafereo
Stephen Y. Lai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1369780

6,506 views
8 citations